Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers

NCT05940272 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT05940272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05940272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
July 3, 2023
Completion date
July 3, 2028
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dlbcl - diffuse large b cell lymphoma, large b-cell lymphoma, large-cell lymphoma, lymphoma, lymphoma, b-cell, mediastinal b-cell diffuse large cell lymphoma